A phase 2 study of KX2-391, an oral inhibitor of Src kinase and tubulin polymerization, in men with bone-metastatic castration-resistant prostate cancer
Titel:
A phase 2 study of KX2-391, an oral inhibitor of Src kinase and tubulin polymerization, in men with bone-metastatic castration-resistant prostate cancer
Auteur:
Antonarakis, Emmanuel S. Heath, Elisabeth I. Posadas, Edwin M. Yu, Evan Y. Harrison, Michael R. Bruce, Justine Y. Cho, Steve Y. Wilding, Gregory E. Fetterly, Gerald J. Hangauer, David G. Kwan, Min-Fun R. Dyster, Lyn M. Carducci, Michael A.